Quarterly Case Based Webinars

Only available as part of a package

If you are seeing this page, then you are not signed or have not yet enrolled in the City of Hope/VA Cancer Genomics in Practice course. To begin your enrollment, return to the homepage by clicking the button below, then sign in and click the yellow "ENROLL" button at the top right of the page.

HOMEPAGE

If you need assistance, contact us at CGEP@coh.org.

GCRA Case-based Webinars

COH/VA Genetic Cancer Risk Assessment (GCRA) Case-based Webinars are a central source of practice-centered skills development for participants in the COH/VA Cancer Genomics in Practice course. During case-based webinars inter-professional faculty present, discuss, and apply evidence-based resources to guide genetically informed patient care and address real-world challenges related to diverse cases from GCRA practices. Case-based webinars in the City of Hope program have been demonstrated to generate new learning, reinforce existing knowledge, and help participants identify and address individual learning and skills deficits. Participants seeking a Final Certificate of Completion for the course are required to engage in four live or recorded case-based webinars and complete a post-webinar feedback evaluation form for all four sessions while engaged in the course.

Objectives

  • Observe the process of genetic cancer risk assessment (GCRA) in a collaborative inter-professional case conference setting
  • Apply mutation probability and empiric cancer risk models to actual clinical cases
  • Discern the characteristics of personal/patient history to develop differential diagnoses
  • Develop appropriate genetic testing strategies for patients and at-risk family members
  • Identify strategies to address patient and family communication, ethical, legal, psychosocial, and insurance issues
  • Demonstrate the ability to interpret genetic test results
  • Incorporate evidence-based guidelines and resources to develop personalized cancer risk management plans for patients
  • Recognize key tumor and germline signatures indicating candidacy for targeted treatments by cancer type
  • Identify strategies to address patient and family communication, ethical, legal, psychosocial, and insurance issue
Components visible upon registration.